NCT03769961 (ATAX) is a clinical trial of No intervention in Essential Tremor, sponsored by Oregon Health and Science University.

Who is sponsoring NCT03769961?

NCT03769961 is sponsored by Oregon Health and Science University.

What drugs are being tested in NCT03769961?

Interventions in NCT03769961: No intervention.

What condition does NCT03769961 study?

NCT03769961 studies Essential Tremor, Deep Brain Stimulation, Ataxia, Cerebellar Diseases.

Is NCT03769961 still recruiting?

NCT03769961 is currently terminated. Last updated 17 September 2020.

Last reviewed 2020-09-17 · How we verify

NCT03769961: ATAX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ataxia in Essential Tremor: Describing the Differences Between Disease Process and Treatment Effect

Terminated Last updated 17 September 2020

What this trial tests

trial testing No intervention in Essential Tremor in 6 participants. Terminated before completion.

Timeline

1 December 2018

Primary endpoint
14 September 2020

14 September 2020

Quick facts

Lead sponsor	Oregon Health and Science University
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	6
Start date	1 December 2018
Primary completion	14 September 2020
Estimated completion	14 September 2020
Sites	2 locations across United States

Drugs / interventions tested

No intervention

Conditions studied

Essential Tremor — all drugs for Essential Tremor →
Deep Brain Stimulation — all drugs for Deep Brain Stimulation →
Ataxia — all drugs for Ataxia →
Cerebellar Diseases — all drugs for Cerebellar Diseases →

Sponsor

Oregon Health and Science University

Who can join

Adults 18 to 80, any sex, with Essential Tremor or Deep Brain Stimulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study aims to characterize ataxia occurring in essential tremor and essential tremor with DBS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Deep Brain Stimulation for the Management of Refractory Neurological Disorders: A Comprehensive Review.
Rissardo JP, Vora NM, Tariq I, Mujtaba A, et al · · 2023 · cited 17× · PMID 38004040 · DOI 10.3390/medicina59111991

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Essential Tremor

Currently open trials in the same condition.

NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
NCT07172295 — Modulate Tremor Severity With Low-intensity Focused Ultrasound Stimulation Targeting the Deep Nucleus of Patients With R · NA · recruiting
NCT07016425 — Temporal Interference for Essential Tremor · NA · recruiting
NCT07049003 — Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor · Phase 1 · recruiting
NCT06428526 — Impact of Sensory Electrical Stimulation on Sensation and Tremor · NA · active not recruiting

Other Oregon Health and Science University trials

Trials by the same sponsor.

NCT07431970 — Assessing Construction Execution Under Sleep Impairment · NA · not yet recruiting
NCT07309757 — Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD) · not yet recruiting
NCT07282639 — App-Based Certified Diabetes Education Therapy (AB-CDE) · NA · not yet recruiting
NCT07322588 — Reentry Incentives and Support for Engagement With Contingency Management · NA · not yet recruiting
NCT07220590 — Implementing Powered Mobility in Early Childhood Settings for Children With Cerebral Palsy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03769961 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oregon Health and Science University
Last refreshed: 17 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03769961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing